Home
About
Biofoundry Services
News
People
Partnering
Careers
Contact
Home
About
Biofoundry Services
News
People
Partnering
Careers
Contact
Latest Articles
Category
Select Category
Funding
News
Research
Team
News
April 2022
ISOGENICA COLLABORATES WITH BIOFOUNDRY BIOTECH PHENOTYPECA THROUGH Medilink GRANT AWARD
News
March 2022
Phenotypeca secures commercial contract with Isogenica
News
February 2022
Phenotypeca wins Bioinformatics commercial contract with Tribune Therapeutics
News
January 2022
Phenotypeca wins a third grant from Innovate UK
Team
January 2022
Phenotypeca strengthens the team with the appointment of Senior Research Scientist, Maria Romero
Team
January 2022
Appointment of Neil Dodsworth brings over 30 years of experience to Phenotypeca
News
January 2022
Phenotypeca announces commencement of ‘Lab 4.0’ Project
Funding
December 2021
Phenotypeca starts important vaccine development project
Team
November 2021
Phenotypeca appoints Financial Director following the latest wave of investment.
Research
October 2021
Phenotypeca and the Spider Lab at the University of Nottingham announce groundbreaking collaboration to facilitate large-scale, low-cost production of spider silk for use in medicine.
Team
October 2021
Phenotypeca appoints HR veteran as part of continued commitment to rapid growth.
Team
October 2021
Sarah Hewitt joins Phenotypeca as Senior Research Scientist
Team
September 2021
Phenotypeca expands their Board, with the appointment of David Grinham as a Non-Executive Director
News
August 2021
Phenotypeca raises an additional £450,000 seed investment and further enhances its Board.
Team
August 2021
Charlotte Smith joins the Phenotypeca team to expand the research team
News
July 2021
Expansion of Phenotypeca’s Yeast Biofoundry with a mission to make medicines more affordable and accessible to all that need them.
Team
July 2021
Phenotypeca expands team with the appointment of Dr Emanuele Kendrick at its facilities at the University of Nottingham
Research
June 2021
“Optimising the Language of Life for Recombinant Protein Manufacture”– The Royal Society Awards a Short Industry Fellowship to Automate Gene Design for Phenotypeca’s Yeast Expression Platform.
Team
June 2021
Phenotypeca expands team with new project management role
Team
May 2021
Dr Christian Gude joins the Phenotypeca team as Research Scientist
News
March 2021
Nottingham synthetic biology company secures significant equipment deal from biotechnology company and world-leading albumin manufacturer, Albumedix, with D2N2 Growth Hub support
Funding
February 2021
Phenotypeca raises £300,000 seed investment and strengthens its board
News
February 2021
IN THE NEWS - Vax-Hub’s February Newsletter featuring Phenotypeca
®
focuses on academic-industry partnerships and vaccine technology
News
January 2021
PRESS RELEASE: Nottingham start-up develops novel baker’s yeast for the low-cost manufacture of therapeutic proteins, vaccines and diagnostics.
Team
December 2020
Phenotypeca Ltd expands its Board of Directors, welcoming Simon Chalk as their new Non-Executive Director
Funding
November 2020
Phenotypeca win Feasibility Study funding from the Future Vaccine Manufacturing Research Hub (Vax-Hub) in partnership with The Jenner Institute
Team
October 2020
Phenotypeca welcome molecular biology specialist, Dr Cindy Vallières, to their research team
Team
September 2020
Phenotypeca is honoured to appoint Patrick Florent as non-Executive Chairman of the Board
Team
August 2020
Phenotypeca engages grant writing specialist, Dr Emma Richardson, to lead a non-dilutive funding strategy at the end of August
News
July 2020
Phenotypeca move into BioCity Nottingham
Funding
June 2020
Phenotypeca wins IUK grant for the 'rapid response to COVID-19' competition
Team
May 2020
Phenotypeca is delighted to appoint Dr David Harvey to help deliver on our research projects
News
March 2020
Phenotypeca successfully complete first quarter of Innovate UK Project with Invizius and CPI
Funding
March 2020
Phenotypeca wins a voucher to explore how the genetic diversity of
Saccharomyces cerevisiae
can be exploited for the production of VLPs with The Future Vaccine Manufacturing Research Hub (Vax-Hub)
Team
January 2020
Phenotypeca is delighted to have employed Dr Anne Henstra to help deliver the IUK project won in December over the next 16 months.
Funding
December 2019
Phenotypeca wins £373,000 Innovate UK SMART Grant to develop second generation
S. cerevisiae
hosts for enhanced protein yield and quality
Team
November 2019
Phenotypeca is delighted to appoint Patrick Florent from GSK Vaccines and patent attorney Anton Hutter to our Advisory Board
Research
October 2019
Phenotypeca commences a second R&D project using baker’s yeast in their synthetic biology platform
Research
September 2019
Phenotypeca to start research in the Synthetic Biology Research Centre at the University of Nottingham’s Biodiscovery Institute
Team
August 2019
Phenotypeca is delighted to have Dr Les Evans join their team on 1st August
News
July 2019
Phenotypeca applies for an Innovate UK Smart Grant to develop second generation
S. cerevisiae
hosts for enhanced protein yield and quality
Team
June 2019
Phenotypeca is delighted to engage the services of Professor Ed Louis to lead their genomics programme
Team
March 2019
Phenotypeca move to Poplars Court, Lenton Lane, Nottingham
Research
January 2019
Phenotypeca commences R&D with their synthetic biology platform using baker’s yeast (
Saccharomyces cerevisiae
).
News
November 2018
Phenotypeca Limited incorporated today!